Regarding weight loss, the FDA has approved these drugs for people whose body mass index (BMI) is greater than 30 kg/m2, or they have a BMI that is greater than 27 and have a weight-related health problem, such as high blood pressure, sleep apnea, or pre-diabetes
For example, the injections are not recommended for patients who are not clinically overweight with a BMI of 27 or more
Peptides known as GLP-1s, Semaglutide and Tirzepatide are hormones produced in the small intestine that stimulate insulin secretion and inhibit glucagon secretion, thereby lowering blood sugar
Hyponatraemia (low sodium) can occur with escitalopram, particularly in older adults
Neferine, an alkaloid from lotus seed embryos, exerts antiseizure and neuroprotective effects in a kainic acid-induced seizure model in rats